DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/d2aab9/antiobesity_drugs) has announced the addition of the "Anti-Obesity Drugs - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Anti-Obesity Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017.
The Report Profiles 59 Companies Including Many Key and Niche Players Such As:
Arena Pharmaceuticals, Inc., AstraZeneca Plc., F.HOFFMANN-LA ROCHE LTD., GlaxoSmithKline Plc, Orexigen Therapeutics, Inc., and VIVUS, Inc.
Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Key Topics Covered: To view the full extended table of contents, click the link below
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
2. INDUSTRY OVERVIEW
- Market Yet to Unlock Potential
- Obesity: An Unmet Medical Need
- Obesity - A Global Epidemic
- Trends and Issues
- Rising Demand for Obesity Therapeutics
- Growing Emphasis on Metabolism
- Barriers to Development of Effective Drugs
- New Research Aids in Discovery of Novel Drugs
- Growing Problem of Obesity in Asia Particularly China
- Online Drug Stores Boost Sales
3. COMPETITION
- Roche Leads the Race
- Withdrawal of High-Revenue Generating Drugs Affects Competition Metrics
- Competition Grows with Pipeline Drugs
- Current Anti-Obesity Drugs in Pipeline: 2011
4. OBESITY - AN INTRODUCTION
- Diagnosis of Obesity
- BMI Calculation and Classification
- Waist Circumference and BMI
- Causes of Obesity
- Unhealthy Eating Habits
- Environmental and Genetic Factors
- Sedentary Lifestyle
- Alcohol Intake
- Childhood Obesity
- Psychological Factors
- Pregnancy
- Hormonal Disorders
- Drugs
- Aging
- Risks Associated with Obesity
5. OBESITY TREATMENT
- Dietary Therapy
- Exercise Therapy
- Behavior Therapy
- Pharmacotherapy
- Weight Loss Surgery
- Invasive Vis--vis Non-invasive Procedures
- A Brief Review of Select Invasive Procedures
- Bariatric Surgery
- Laparoscopic Adjustable Gastric Banding
- Vertical Banded Gastroplasty (VBG)
- Roux-en-Y Gastric Bypass Procedure (RYGB)
- Lap-Band Procedure
- Gastric Band Procedure
- Gastric Bypass Procedure
- Doudenal Switch
- Prescription Drugs Vis--vis Non-Prescription Drugs
6. ANTI-OBESITY DRUGS - AN INSIGHT
7. PRODUCT APPROVALS/LAUNCHES
8. RECENT INDUSTRY ACTIVITY
9. CORPORATE INITIATIVES IN THE RECENT PAST - A PERSPECTIVE BUILDER
10. FOCUS ON SELECT PLAYERS
11. GLOBAL MARKET PERSPECTIVE
12. THE UNITED STATES
13. EUROPE
14. REST OF WORLD
For more information visit http://www.researchandmarkets.com/research/d2aab9/antiobesity_drugs
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
There are no comments yet